FDA Inspection 873626 — Rivopharm S.A.
The FDA completed an inspection of Rivopharm S.A. on April 3, 2014 in Manno. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 3, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Manno (Switzerland)